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Introduction 
Although the transition zone (TZ) of the prostate 
accounts for less than 5% to 10% of the prostate 
gland volume, its significance for both benign and 
malignant pathologies cannot be underestimated [1, 
2]. It is the exclusive site of origin of benign pros-
tatic hyperplasia with a minor contribution from the 
periurethral glands [1, 3]. The transition zone also 
has clinical relevance in patients with prostate can-
cer and its evaluation may be useful for diagnosis, 
staging, and treatment planning [4, 5].
Moreover, the measurements of the transition 
zone volume (TZV), which corresponds to the vol-
ume of the adenoma, often determine the modality 
of treatment for benign prostatic hyperplasia (BPH), 
including minimally invasive techniques and surgical 
approach [6].
Is determination of transition zone volume by transrectal 
ultrasound in patients with clinically benign prostatic 
enlargement sufficiently reliable in the clinical setting?
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A b s t r a c t
Introduction: Controversies exist regarding the accuracy of transrectal ultrasound (TRUS) determination of transition 
zone volume (TZV) when compared with enucleated adenoma weight.
Aim: To determine the accuracy and reliability of measurements of the TZV by TRUS, by comparing preoperative ra-
diological findings with the enucleated prostate adenoma volume, measured by fluid displacement volumetry (FDV), 
after retropubic prostatectomy performed by the Millin method, and, moreover, to evaluate changes in the surgical 
capsule size in the intermediate postoperative period.
Material and methods: We measured TZV preoperatively using TRUS and postoperatively with FDV in 112 patients 
who underwent retroperitoneal prostatectomy for benign prostatic hyperplasia (BPH).
Results: The TRUS volume correlated well with specimen volumes (r = 0.945, p < 0.0001). The median (quartile 1, 
quartile 3) absolute error was 7.35 ml (4.15 ml, 9.28 ml) and the median percent error was 9.12% (4.75%, 14.98%). 
Percent error, but not absolute error, was significantly related to TRUS TZV (p < 0.001 and 0.217, respectively). Ade-
nomas > 80 cc were associated with lower percent error. The median volume of the residual prostate tissue measured 
3.5 years after prostatectomy was 92.65 cc (65.75 cc, 109.58 cc), whereas the median volume of the surgical capsule, 
depending on the equation used for its calculation, was 24.80 cc (16.25 cc, 37.37 cc) and 31.43 cc (23.14 cc, 43.32 cc).
Conclusions: The TRUS TZV correlated well with values determined by FDV. It can be reliably used in clinical manage-
ment of BPH.
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The entire prostate and TZ volumes are most 
commonly estimated with transrectal ultrasound 
(TRUS). However, TZV measurement is operator de-
pendent [7, 8]. Moreover, controversies exist regard-
ing the accuracy of TRUS determination of TZV when 
compared with enucleated adenoma weight. While 
some authors have reported significant discrepan-
cies [9, 10] others have found no differences [11, 
12]. However, as all studies included a limited num-
ber of patients, some analysed specimens were only 
obtained following transurethral resection of the 
prostate or after suprapubic prostatectomy, or TZV 
determined by TRUS was compared with measured 
weight, the conclusions reached could have been ad-
versely affected.
Aim
Therefore, the aim of this study was to deter-
mine the accuracy and reliability of measurements 
of TZV by transrectal ultrasound, by comparing 
preoperative radiological findings with the enucle-
ated prostate adenoma volume, measured by fluid 
displacement volumetry, after retropubic prostatec-
tomy performed by the Millin method. Moreover, 
we evaluated the residual prostate tissue by TRUS 
3.5 years after the procedure to assess changes in 
its volume in the intermediate postoperative period.
Material and methods 
The study was approved by the local research 
ethics committee, and all the procedures were car-
ried out in accordance with the Helsinki Declara-
tion of 1975, as revised in 1983. One hundred and 
twelve consecutive patients, who underwent ret-
ropubic prostatectomy (Millin operation) for histo-
logically confirmed BPH, were included. All patients 
underwent TRUS before surgery, performed using 
a  model 3535 Brüel and Kjaer (Denmark) system 
with a 7 MHz multiplanar transrectal transducer. The 
prostate was scanned in the transverse and sagittal 
planes with the subjects in the left lateral decubi-
tus position. Preoperative and postoperative pros-
tate volumes were determined using the formula for 
a  prolate ellipsoid (π/6 × width × length × height) 
[13]. The width was the longest section on the trans-
verse scan, length was the greatest anteroposteri-
or distance on a sagittal scan, and height was the 
longest cephalic to caudal dimension in the sagittal 
plane.
The transverse, anteroposterior, and longitudinal 
dimensions of the transition zone were measured in 
the same planes in which total prostate dimensions 
were determined. The width of the TZ was mea-
sured starting from the inner part of the capsule, the 
length from the inner part of the capsule to the clear 
limit of the TZ at the verumontanum, and height 
from the bladder neck to the clear inferior limit. The 
volume of the TZ was estimated using the prolate 
ellipsoid formula.
The volume of the enucleated prostate adenoma 
was assessed immediately after the surgery using 
fluid displacement volumetry [14]. For this, the pros-
tate adenoma specimen was placed in a transparent 
container filled with normal saline solution and the 
initial and final volumes were measured. The pros-
tate volume was equal to the difference between 
final and initial volumes. 
The volume of residual prostate tissue imme-
diately after surgery, i.e. the surgical capsule, was 
calculated using two equations: i) by subtracting 
TZ volume from preoperative prostate volume mea-
sured by TRUS and ii) by subtracting prostate adeno-
ma volume measured by fluid displacement volum-
etry from preoperative prostate volume determined 
by transrectal ultrasound.
To gauge the accuracy of TRUS volume, for es-
timating specimen volume determined by fluid dis-
placement volumetry we calculated the absolute 
error using the formula: TRUS TZ volume (TZV) – ad-
enoma volume measured by fluid displacement vol-
umetry (AV). Similarly, the percent error in measure-
ment was calculated using the following formula: 
[TZV – AV]/AV × 100%.
Statistical analysis
Since data in the studied group were not distrib-
uted in a Gaussian manner, the difference in medi-
an prostate adenoma volume and median TZV was 
evaluated by the Mann-Whitney U test. A p value of 
< 0.05 was considered statistically significant. The 
Statistical Package for the Social Sciences (SPSS) 
was used for all statistical analyses.
Spearman’s correlation coefficient and linear 
regression analysis were applied to determine the 
correlation of preoperative and postoperative pros-
tate gland with TZV measured by the immersion 
method. The degree of association of the enucleat-
ed adenoma volume, measured by the immersion 
method with estimated transrectal ultrasound vol-
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ume of the transition zone, was also calculated by 
Spearman’s correlation coefficient. The dependence 
of prostate adenoma volume, evaluated by the im-
mersion method, on TZV was evaluated by linear 
regression analysis. Spearman’s correlation coeffi-
cient and simple linear regression were used to de-
termine the correlation of residual prostate tissue 
calculated immediately postoperatively with resid-
ual prostate measured 3.5 years following surgery. 
The difference in median prostate adenoma volume 
and median TZV was evaluated by the Mann-Whit-
ney U test. 
Results
The median values of volumes determined in 
112 patients are presented in Table I. The median 
(low quartile, high quartile) TZV measured by TRUS 
was 81.65 cc (70.53 cc, 99.90 cc), whereas the cor-
responding volume of the enucleated adenoma was 
80.00  ml (61.00 ml, 93.00 ml). The difference be-
tween the estimate with TRUS and the surgical spec-
imen was statistically significant (p < 0.001). 
The median volume of the entire prostate deter-
mined by TRUS preoperatively was 114.34 cc (96.38 cc, 
130.13 cc). The median volumes of the surgical 
capsule calculated by subtraction of TZV from pre-
operative prostate volume measured by TRUS, and 
also by subtracting prostate adenoma volume, mea-
sured by fluid displacement volumetry, from preop-
erative prostate volume determined by transrectal 
ultrasound were 24.80  cc (16.25 cc, 37.37 cc) and 
31.43 cc (23.14 cc, 43.32 cc), respectively.
The correlation between the TZV estimated 
by TRUS and by fluid displacement volumetry (r = 
0.945, p < 0.0001, Figure 1) was statistically signif-
icant. The correlations between the adenoma vol-
ume measured by fluid displacement volumetry and 
the preoperative prostate volume estimated by TRUS 
(r = 0.633, p < 0.0001, Figure 2), and between the 
Table I. Patient demographics, TRUS volume, 
specimen volume, absolute and percent errors
Variable N Value
Age, mean ± SD 112 70.58 ±5.93
Median TPV (Q1, Q3) 112 114.34 (96.38, 130.13)
Median TZV (Q1, Q3) 112 81.65 (70.53, 99.90)
Median AV (Q1, Q3) 112 80.00 (61.00, 93.00)
Median TPV3 (Q1, Q3) 112 92.65 (65.75, 109.58)
p Value TZV vs. AV 112 < 0.001
Median TZV-AV (Q1, Q3) 112 7.35 (4.15, 9.28)
Median TPV-AV (Q1, Q3) 112 31.43 (23.14, 43.32)
Median TPV-TZV (Q1, Q3) 112 24.80 (16.25, 37.37)
TZV/AVx100% 112 91.65 (86.98, 95.47)
TPV/AVx100% 112 70.05 (59.73, 78.70)
TPV3/AVx100% 112 85.73 (70.48, 106.41)
Absolute error  
(entire group)
112 7.35 (4.15, 9.28)
Percent error  
(entire group)
112 9.12 (4.75, 14.98)
Absolute error (TZ ≤ 80cc) 48 8.10 (5.30, 9.78)
Percent error (TZ ≤ 80cc) 48 13.68 (8.27, 16.48)
Absolute error  
(TZ > 80cc)
64 6.55 (2.93, 9.00)
Percent error (TZ > 80cc) 64 6.69 (3.07, 9.68)
p Value for absolute  
error ≤ 80 cc vs. ≤ 80 cc 
112 0.217
p Value for percent  
error ≤ 80 cc vs. ≤ 80 cc
112 < 0.001
Mean age is expressed in years; SD – standard deviation, SD is expressed in 
years, TPV – total prostate volume estimated preoperatively by TRUS, TZV 
– transition zone volume estimated preoperatively by TRUS, AV – adenoma 
volume determined by fluid displacement volumetry, TPV3 – residual pros-
tate tissue volume estimated by TRUS 3.5 years after retropubic prostatec-
tomy; TZV/AVx100% – the median percent of TZV estimated preoperatively 
by TRUS that corresponds to adenoma volume determined by fluid displace-
ment volumetry; TPV/AVx100% – the median percent of TPV estimated 
preoperatively by TRUS that corresponds to adenoma volume determined 
by fluid displacement volumetry; TPV3/AVx100% – the median percent of 
TPV3 estimated by TRUS 3.5 years after retropubic prostatectomy that cor-
responds to adenoma volume determined by fluid displacement volumetry, 
vs. – versus, n – number of patients
Figure 1. Scatterplot and line of best fit for TRUS 
TZV as function of specimen volume (AV) esti-
mated by fluid displacement volumetry
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adenoma volume measured by fluid displacement 
volumetry and residual prostate tissue determined 
by TRUS on average 3.5 years (42 months) (± SD = 
6.51 months) after surgery (r = 0.407, p < 0.0001, 
Figure 3), were both statistically significant. No cor-
relation was found between the surgical capsule cal-
culated immediately after surgery and estimated by 
TRUS 3.5 years after retropubic prostatectomy. 
Overall, median absolute error was 7.35  ml 
(4.15 ml, 9.28 ml), and median percent error was 
9.12% (4.75%, 14.98%). Percent error was significant-
ly associated with TRUS TZV with higher TRUS vol-
umes associated with lower percent error (p < 0.001). 
The greatest percent error was seen in patients with 
TRUS TZ volume of 80 cc or less (Figure 4).
Discussion
Accurate measurement of the prostate gland size 
is important in clinical settings as it determines BPH 
management and prostate cancer risk classification. 
The volume of the TZ of the prostate influences the 
choice of surgical technique in patients with symp-
tomatic benign prostatic hyperplasia [6]. The TRUS 
has been the most commonly used method for TZV 
estimation. Although it remains a gold standard in 
determining prostate size in patients with benign 
disease, it is not, however, without inaccuracies 
[7, 8]. The accuracy of prostate TZV estimations in 
patients with BPH has been a  subject of several 
studies, but these have involved either small co-
horts, limiting their analyses to specimens obtained 
following transurethral resection of the prostate or 
after suprapubic prostatectomy, or compared TZV 
determined by TRUS with measured weight [9, 11, 
12]. Whereas prostate weight and volume are the-
oretically interchangeable since the specific gravity 
of prostate tissue is 1.05, only the former is a true 
measurement and the latter is mathematically cal-
culated [15]. Hence, there is a  potential risk that 
conclusions drawn based on the above association 
Figure 2. Scatterplot and line of best fit for TRUS 
total prostate volume (TPV) as function of spec-
imen volume (AV) estimated by fluid displace-
ment volumetry
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Figure 3. Scatterplot and line of best fit for re-
sidual tissue volume estimated by TRUS 3.5 
years following surgery (TPV3) as function of 
specimen volume (AV) estimated by fluid dis-
placement volumetry
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Figure 4. Box plot of percent error shows num-
ber and percent of patients per category for 
TRUS TZV of ≤ 80 cc and > 80 cc
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would be invalid. In the present study we sought to 
determine the general comparability of estimated 
volumes by TRUS when compared with volumes de-
termined by fluid displacement volumetry.
In our cohort of 112 men who underwent retro-
pubic prostatectomy for symptomatic BPH, we found 
that TRUS TZV estimation correlated well with vol-
ume of adenoma specimen determined by fluid dis-
placement volumetry (r = 0.945, p < 0.0001).
Consistent with other reports, we found that 
TRUS volume accuracy (expressed in this study as 
percent error) depends on TRUS volume [16–18]. In 
the present study, men with smaller adenoma vol-
ume (< 80 cc) had the greatest percent error. 
In a study by Matthews et al., TRUS volume over-
estimation was noted in glands smaller than 30 cc 
and underestimation in larger than 50 cc [19]. Terris 
and Stamey noted that it may be more accurate to 
apply a prolate spheroid formula, for smaller glands 
(less than 80 g), and use other equation for larger 
prostates [16].
In our study median TRUS TZV was 81.65 cc 
(70.53 cc, 99.90 cc) and median retropubic prosta-
tectomy specimen volume was 80.00 ml (61.00 ml, 
93.00 ml), giving a correction factor of (80.00/81.65) 
= 0.97. In terms of clinical accuracy, the fact that 
the correction factor was not much different than 
1.0 implies that TRUS volume can be used clinically 
without correction. 
In addition, although percent error depended on 
TRUS volume, the absolute error was not affected by 
prostate size (8.10 ml and 6.55 ml in ≤ 80 cc and 
> 80 cc, respectively, p = 0.217). Therefore, TRUS can 
be used to estimate TZV regardless of its size.
In this study we also estimated volume of the 
residual tissue following retropubic prostatectomy 
(i.e. surgical capsule) and correlated it to the TRUS 
measurement performed 3.5 years after surgery. 
Median volume of the surgical capsule calculated by 
subtracting TZV from preoperative prostate volume 
both measured by TRUS, and by subtracting pros-
tate adenoma volume measured by fluid displace-
ment volumetry from preoperative prostate volume 
determined by TRUS, was 24.80 cc (16.25 cc, 37.37 cc) 
and 31.43 cc (23.14 cc, 43.32 cc), respectively. The 
difference between those two estimations was sta-
tistically significant (p < 0.001). Interestingly, median 
volume of the residual prostate tissue measured by 
TRUS 3.5 years after prostatectomy was 92. 65 cc 
(65.75 cc, 109.58 cc). Hence, it was approximately 
3 times larger than the calculated volume of tissue 
at the time of surgery, irrespective of whichever 
equation we used. However, there are two notewor-
thy limitations of this study that could affect esti-
mation of volume of the residual prostate tissue in 
the intermediate follow-up period. These include the 
exclusive use of calculation-based determination of 
volume of the surgical capsule without TRUS mea-
surements in the early period after surgery which 
would be long enough to allow for oedema to sub-
side but not allow for bio-mechanical processes to 
develop and affect measurements, also not taking 
into account the volume of the resected bed while 
estimating the size of the residual tissue in the in-
termediate follow-up period.
However, we believe that such a significant in-
crease in median volume of the residual tissue ob-
served 3.5 years after prostatectomy as compared 
to the preoperational values cannot simply be ex-
plained by inaccuracy in the method we used to 
estimate volume of the surgical capsule prior to 
surgery. Moreover, since the Millin retropubic pros-
tatectomy was performed in all cases, a  complete 
enucleation of the adenoma is more than expected. 
Also, significant neohyperplasia of the residual tis-
sue, that could result in a marked increase of its vol-
ume, seems to be unlikely, as the enucleation was 
complete and the follow-up period was not long 
[18]. Therefore, occurrence of bio-mechanical pro-
cesses in the residual tissue need to be considered. 
These may include relaxation of collagen fibres 
which are an important component of the prostatic 
peripheral zone tissue [20].
Conclusions
The TRUS volume correlated well with values de-
termined by fluid displacement volumetry. The per-
cent error in TRUS volume estimation depends on 
the measured volume with the highest accuracy in 
men with TZV > 80 cc. However, absolute error was 
not affected by volume. Therefore, TRUS estimation 
of TZV is reliable and can be used clinically without 
correction. Further research should look into pro-
cesses occurring within residual prostate tissue and 
their significance for clinical practice.
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